Abiologics

Abiologics is developing SynteinsTM, a groundbreaking class of fully synthetic proteins that utilize artificial building blocks like D-amino acids. Targeting the biopharmaceutical market, these proteins offer enhanced oral stability and immune evasion, pushing beyond the constraints of traditional biologics with their programmable nature.